SEER logo

SEER

Seer Inc.

$1.97
+$0.03(+1.55%)
39
Overall
60
Value
18
Tech
--
Quality
Market Cap
$123.85M
Volume
166.36K
52W Range
$1.62 - $2.63
Target Price
$3.00

Company Overview

Mkt Cap$123.85MPrice$1.97
Volume166.36KChange+1.55%
P/E Ratio-1.4Open$1.95
Revenue$14.2MPrev Close$1.94
Net Income$-86.6M52W Range$1.62 - $2.63
Div YieldN/ATarget$3.00
Overall39Value60
Quality--Technical18

No chart data available

About Seer Inc.

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Sector: Professional, Scientific, and Technical Services
Industry: Testing Laboratories

Latest News

Analysts Offer Insights on Healthcare Companies: Seer (SEER), Rocket Pharmaceuticals (RCKT) and OnKure Therapeutics (OKUR)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Seer (SEER – Research Report), Rocket Pharmaceutical...

Catie Powers16 days ago
ABCD
1SymbolPriceChangeVol
2SEER$1.97+1.5%166.36K
3
4
5
6

Get Seer Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.